Microcap Ledger Bioventus Inc. $BVS
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Select Market
- Sector
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Durham, NC
- Fiscal year end
- December 31
What the company doesAI summary of filing
Bioventus Inc. is a revenue-generating global medical device company that sells products for pain relief, surgical applications, and bone healing through three business units: Pain Treatments & PRP (including hyaluronic acid injections for knee osteoarthritis and peripheral nerve stimulation devices), Surgical Solutions (ultrasonic bone-cutting systems and bone graft substitutes), and Restorative Therapies (ultrasound bone stimulation for fracture healing). The company sells its products through direct and indirect sales teams to physicians in office, surgical center, and hospital settings in the United States and internationally, with the U.S. accounting for 88% of net sales in fiscal year 2025. [10-K 2026-03-05]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $285.30M | $36.55M | $28.81M | $29.46M | [10-Q 2026-08-05] |
| FY ended Dec 2025 | $568.09M | $22.73M | $74.67M | $51.24M | [10-K 2026-03-05] |
| FY ended Dec 2024 | $573.28M | −$36.13M | $38.80M | $41.58M | [10-K 2026-03-05] |
Capital structure and dilution
- Shelf registration
- S-3 filed 2024-10-25; declared effective 2024-11-04 [S-3 2024-10-25]
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-06-02 | Bartholdson John A. | exercise | 32,282 | — | [4 2026-06-04] |
| 2026-06-02 | Sutter Martin P | exercise | 32,282 | — | [4 2026-06-04] |
| 2026-06-02 | Stalnecker Susan M | exercise | 32,282 | — | [4 2026-06-04] |
| 2026-06-02 | Nohra Guy P | exercise | 32,282 | — | [4 2026-06-04] |
| 2026-06-02 | Neels Guido J | exercise | 32,282 | — | [4 2026-06-04] |
| 2026-06-02 | Mcmurry-Heath Michelle | exercise | 32,282 | — | [4 2026-06-04] |
| 2026-06-02 | Ladone Mary Kay | exercise | 32,282 | — | [4 2026-06-04] |
| 2026-06-02 | Hawkins William A | exercise | 39,789 | — | [4 2026-06-04] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-05 | 10-Q | Quarterly report |
| 2026-08-05 | 8-K | Results of operations; Other events |
| 2026-07-27 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-06-04 | 8-K | Shareholder vote results |
| 2026-05-21 | 8-K | Regulation FD disclosure |
| 2026-05-06 | 10-Q | Quarterly report |
| 2026-05-06 | 8-K | Results of operations |
| 2026-04-22 | DEF 14A | Proxy statement |
| 2026-03-05 | 10-K | Annual report |
| 2026-03-05 | 8-K | Results of operations |
| 2026-02-13 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2025-11-17 | 8-K | Director or officer change |
Alerts for $BVS
Email me when Bioventus Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.